Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine
Sanofi Pasteur and Translate Bio this week announced plans to collaborate to develop a novel messenger RNA (mRNA) vaccine for COVID-19. ...
Tag: Vaccines
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them?
SARS-CoV-2 – the coronavirus that causes the disease COVID-19 – is completely new and attacks cells in a novel way. ...
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices
PharmaJet has announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of ...
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of ...
Hotel Influenza: Research Heats Up on Universal Flu Vaccines
A universal flu vaccine has eluded scientists for decades. Unlike other viruses, influenza has a rapid-fire mutation rate and thousands ...
Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. Pfizer Inc. and BioNTech SE today announced ...
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Coronavirus Vaccine
Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the first participant ...
CEPI Gets €140 Million Funding Boost From Germany While Expanding Coronavirus Vaccine Search
The German Government’s Federal Ministry of Education and Research announced on Mar. 11 an additional €140 million (US$157 million) to ...
BAA for COVID-19 Diagnostics, Vaccines and Therapeutics
As part of the government-wide effort to mitigate the spread of COVID-19 in U.S. communities, the U.S. Department of Health ...
Viral Vaccines to Combat SARS-CoV-2 Pneumonia
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly. Development of SARS-CoV-2-based vaccines is ...
The Case for a Seven-Gene-Deleted African Swine Fever Virus vs. Live Attenuated Vaccine
African swine fever (ASF) is a devastating infectious disease in swine that is severely threatening the global pig industry. An ...
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform
Soligenix, Inc. announced that its ongoing collaboration with the University of Hawai’i at Manoa (UHM) and Hawaii Biotech Inc. (HBI) ...
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership
Daniel Menichella, CEO of biopharmaceutical company CureVac, was today invited to the White House to discuss strategies and opportunities for ...
Senator Markey Introduces Legislation to Invest $1 Billion in Universal Coronavirus Vaccine
Senator Edward J. Markey (D-Mass.) today introduced legislation to conduct or support comprehensive research for the creation of a universal ...
University of Queensland COVID-19 Vaccine Goes Into Test Production
A University of Queensland team has met a key milestone in their fast-tracked research to develop a vaccine for the ...
JLABS @ Washington DC Seeks Innovations for Pediatric Influenza Interventions
Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total ...
Tulane National Primate Research Center Launches Coronavirus Research Program
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing ...
HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine
Racing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department of Health and Human Services’ Office of ...
J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research ...
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning
Soligenix, Inc. announced on Feb. 13 that its RiVax® (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication ...
